Jaeseong Bio IPO
Jaeseong Bio IPO
What do you think is the number one stock that Korean investors want to own the most?
It could have been a top-tier conglomerate currently holding the number one spot, or perhaps a promising startup. But it was neither. The glorious protagonist of the number one domestic stock that investors coveted most was none other than Jaeseong Bio.
However, that was a fantasy that couldn't be realized in reality. Because Jaeseong Bio's stock was not for sale. They didn't even accept investment proposals in the first place.
They suddenly appeared like a comet and created a dementia treatment. There was no such thing as receiving investments from other investors.
Looking at Jaeseong Bio's equity status, it was very simple.
The founder, Soyeon-nim, held 100% of the shares. If that was the case, it was impossible to know why they maintained the form of a joint-stock company with equity and went public.
But now, the reason would soon be revealed.
[Regarding Jaeseong Bio's IPO]
A ray of good news reached Korean stock investors.
The news of Jaeseong Bio's listing breathed life into the stock investor bulletin board.
[It's here!!!!]
[Jaeseong Bio is going public!!!]
[Ah, I took out a full loan lol. I'm definitely not getting margin called~]
[I should even put up my house deed. If you don't invest in Jaeseong Bio, you're a moron, right?]
[Sigh... Should I just sell my shitty stocks and invest in Jaeseong Bio?]
[What? Jaeseong Bio is going public too? I didn't know it was a joint-stock company.]
[Guys, this is a chance to get rich quick. No suckers missing this opportunity, right?]
Stock investors gathered in clusters, carrying bundles of capital to buy Jaeseong Bio stock.
And so, Jaeseong Bio finished its public offering subscription.
There was no anxiety about whether they would reach the target amount. Capital poured in as soon as the subscription started. Not only did they hit the target public offering price in a single day, but there were also investors wailing because the shutters closed too quickly.
[Current disclosure data regarding Jaeseong Bio's equity ratio]
Soyeon-nim: 51%
Other general shareholders: 49%
Of course, shares were also distributed evenly among the Cultured Humans.
So, if you actually calculate it, you had to combine the equity ratios of Soyeon-nim and the Cultured Humans. They were Jaeseong-gun's subordinates anyway.
The combined equity of both approached about 70%. With this much, unless some major incident occurred, there was no chance of being kicked out after losing the shares. Even if you were the founder, if someone else achieved a 51% equity ratio, you would lose the company.
It wasn't for nothing that it was called a joint-stock company.
[Predicting Jaeseong Bio's stock price~]
Market open (9 AM): Jaeseong Bio stock drops 30% immediately upon market opening.
Mid-market: Hits resistance line, then immediately rebounds about 30%?
Late-mid market: Institutions ghost-like dump on the retail investors and then vertical drop again.
End of market: In a state of being halved, it moves sideways infinitely, sucking up retail investors' funds until the market closes.
Prediction, how's it look?
[Bullshit, no way]
[Do you think a company with a dementia treatment is a joke?]
[For the next 20 years while the patent is valid, it's Jaeseong Bio's world, so why are you writing this moronic post?]
[No, it's not 20 years. It hasn't passed the US FDA yet, so it's not applied lol. The patent starts the moment it passes the US FDA.]
[I see it tripling. Trust me and invest all your assets.]
Thus, even calculating based on the public offering price, Jaeseong Bio's market cap had already entered the top 100 KOSPI-listed companies. If you look closely, they were already making huge sales profits with Neurogen.
It wasn't just domestic dementia patients taking it. Dementia patients from overseas also came to take Neurogen. It's said that Jaeseong Bio's monthly revenue from the dementia treatment alone approaches 5 trillion won.
Annual revenue alone was 60 trillion won.
It wasn't some scam bio company. Neurogen was now proudly making a name for itself as a dementia cure. There was no one in South Korea who doubted Neurogen.
Perhaps because dementia patients regained their new lives, the favorability toward Jaeseong Bio, which created Neurogen, soared to the point where it broke through the graph.
Healthy people probably couldn't fully understand the fear and joy that dementia patients felt. If they were healthy, that is. But dementia patients thought about the fear they felt when they had dementia.
Perhaps that's why they couldn't help but feel relieved at the fact that Jaeseong Bio had created a dementia treatment.
Anyway, Jaeseong Bio's stock market debut was successful. As soon as trading started, the stock price jumped by over 30%. Originally, the upper limit in the KOSPI market was set at 30%.
No matter how good stock investors were at investing, they couldn't make more than a 30% profit in a day with a single stock. But public offering stocks were different. It was possible to rise up to 200%, what is commonly called a 'double'.
The public offering price was 100,000 won.
In the early market, Jaeseong Bio's stock rose to 130,000 won. The upward trend didn't even falter. It was getting faster and faster.
140,000 won
150,000 won
160,000 won
Finally, it reached the 170,000 won mark. Jaeseong Bio's stock price was rising endlessly. It was like a runner. This was an achievement reached despite not even 30 minutes having passed since listing.
Naturally, the investor bulletin boards were in an uproar.
[Grea~~~t~~~Boom~~~~]
[Sell your house, sell your gold, sell your kids, sell everything and buy Jaeseong Bio, it's a guaranteed moon mission]
[Still 30,000 won left~ Let's go to the upper limit~~]
[???: Jaeseong Bio's stock is overvalued. It's a one-trick pony with the dementia treatment.]
[Bullshit lol. A one-trick pony? Lol. That's a fucking strong one-trick pony. There's no dementia treatment in this world other than Neurogen, right?]
[Jaeseong Bio might even hit 180,000 won? People who got in as soon as it listed today are making 80%, crazy.]
[Why work? When you put money in, it just copies itself~]
[Ah, my average price is 100,000 won, it's cozy~ It'll probably just go to 1,000,000 won.]
[Average price 110,000 won, verified]
[No suckers who dumped right after listing, right? It's a stock you win with if you just hold it~]
But perhaps one could say that when mockery reaches its peak, a reversal comes.
Jaeseong Bio's stock price, which had exceeded 180,000 won, began to plummet. Investors who had boasted that it would cross 180,000 won were met with a ghostly drop.
Jaeseong Bio's stock price fell to 150,000 won.
[Ru~~~n~~~ away~~~]
[It's the Great Depression!!!!!]
[Long-positioners, are you coming to your senses?]
[Where is there a stock that keeps going up lol]
[No, fuck!!! I bought it at 180,000 won!!!!]
[I'm at the peak... how many years in prison will this be...?]
[I put all my assets in, and I'm at -20%. I want to die. I'm going to drink a bottle of soju today and head to the Han River Bridge.]
And so, Jaeseong Bio's stock price fell endlessly.
At the point where it fell to 110,000 won.
Of course, even if the market closed like this, those who bought the public offering shares were still in profit. Because Jaeseong Bio's public offering price was 100,000 won.
I don't know what kind of market manipulation group latched onto it, but suddenly the stock price rose again.
The atmosphere of the stock gallery was flipped.
[????]
[What is this! It's going up again?]
[No, it's the only company in the world selling a dementia treatment lol. I told you it's undervalued? I see it going to 1,000,000 won.]
[No suckers who sold at 110,000 won, right~]
[But wouldn't the stock price fall if they make generic drugs or something?]
[It's patented for 20 years, so how could they make generics... Of course, they could make them in underdeveloped countries that don't follow the law. But in the first place, those guys aren't customers who have the money to buy Neurogen, right? They're as good as non-existent customers.]
[It's 100,000 won per pill, would people from underdeveloped countries come all the way to South Korea to take it... They say their monthly salary there is 300,000 won.]
[It seems only rich people living in Europe, the US, or underdeveloped countries will come?]
[They said even just doing that, it's 1 million people.]
Jaeseong Bio's stock price went up and up again.
10 minutes before the market closed.
Jaeseong Bio reached the upper limit.
The stock price that started at 100,000 won had reached 200,000 won. Those who got into the public offering could make a 2x profit overnight.
Soyeon-nim watched the stock price.
It was a huge success.
Besides, there was still much more left.
If you ask why they went public... I should say it's because Jaeseong-gun wanted it.
Jaeseong-gun said he wanted to own the world's number one company.
It's fully achievable even as a private company, but for starters, the figures weren't accurately disclosed.
However, once listed, the company's value was accurately evaluated and measured. In other words, it meant that ranking was possible.
Soyeon-nim looked at Jaeseong-gun sleeping next to her.
Soyeon-nim scanned Jaeseong-gun's body with a sexy and mysterious gaze.
Although she couldn't touch him yet because Jaeseong-gun was a minor... Soyeon-nim was always ready.
She would move and act as Jaeseong-gun wished.